Top Markets
Coin of the day
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
株式のランク #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
株価
$3.78
最終同期: 2026-08-21
時価総額
$71.20M
変化(1日)
2.24%
変化(1年)
-43.37%
FR
取引 MaaT Pharma S.A. (MAAT)

カテゴリー

MaaT Pharma S.A.(MAAT)の株価履歴
終値の最高値: $3.53 (2026-08-01)

終値の最安値: $15.22 (2021-11-01)
MaaT Pharma S.A. の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 10.63%
2025 -39.72%
2024 11.45%
2023 -18.97%
2022 -38.00%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH